Shire Pharmaceuticals Grp PLC acquires AnorMED-Fosrenol Global Patent from AnorMED Inc


CANADA - Shire Pharmaceutical Group PLC acquired the Fosrenol global patents of AnorMED Inc, an own and operate medical laboratories, for ## mil Canadian dollars (##.### mil British pounds/$##.### mil US).

Deal Information

Credit & Investment Research

Market Research

News